Global Hard Gelatin Capsules Market Poised for Robust Growth, Projected to Reach USD 3,409.7 million by 2034 | Future Market Insights, Inc.
The global hard gelatin capsules market is experiencing robust growth, driven by the rapidly expanding nutraceutical sector. As consumers become increasingly health-conscious, there is a significant shift towards preventive healthcare over treatment. This trend has fueled the demand for hard gelatin capsules, which are favored for their efficacy in delivering nutraceuticals. The growing awareness of health and wellness among consumers is a key driver, propelling the market to new heights.
NEWARK, Del, Sept. 04, 2024 (GLOBE NEWSWIRE) — The global hard gelatin capsules market is on a significant growth trajectory, with sales estimated to surge from USD 1,940.3 million in 2024 to an impressive USD 3,409.7 million by 2034. This remarkable expansion reflects a compound annual growth rate (CAGR) of 5.8% over the forecast period.
Understanding the Hard Gelatin Capsules Market:
The hard gelatin capsules market has been experiencing steady growth due to their extensive use in delivering oral medications. This growth is driven by increasing demand for dietary supplements, advancements in pharmaceutical technologies, and the rise in chronic diseases. Hard gelatin capsules are primarily used for encapsulating powders, granules, and pellets. They are commonly used in pharmaceuticals for delivering drugs and in nutraceuticals for dietary supplements.
Market Value and Growth Projections:
The global hard gelatin capsules market is experiencing significant expansion, with projections indicating a substantial increase in value over the next decade. In 2024, the market is expected to generate revenues of approximately USD 1,940.3 million, marking a year-over-year growth of 5.9% compared to the previous year. This growth underscores the increasing demand for hard gelatin capsules, driven by their widespread use in the pharmaceutical and nutraceutical industries.
Market CAGR Value of Hard Gelatin Capsules by Country:
| Countries | Value CAGR (2024 to 2034) |
| USA | 1.80% |
| Germany | 1.80% |
| France | 2.90% |
| UK | 2.10% |
| China | 5.80% |
| India | 6.60% |
| South Korea | 4.60% |
Hard Gelatin Capsules Trends: Find Out More in Our Comprehensive Report Filled with Key Insights! https://www.pharmiweb.com/press-release/2023-07-11/strong-growth-projected-for-hard-gelatin-capsules-market-impressive-cagr-of-64-expected-from-2022
The hard gelatin capsules market is influenced by several key drivers, including:
- Rising Demand for Convenient Dosage Forms: Hard gelatin capsules are popular due to their ease of use, accurate dosing, and the ability to mask unpleasant tastes and odors. This convenience drives their adoption among consumers and healthcare professionals.
- Growing Pharmaceutical and Nutraceutical Industries: The expansion of the pharmaceutical and nutraceutical sectors fuels the demand for hard gelatin capsules. They are widely used for delivering various drugs and dietary supplements.
- Technological Advancements: Innovations in capsule technology, such as the development of customized and enteric-coated capsules, enhance the functionality and appeal of hard gelatin capsules. These advancements help cater to specific medical and consumer needs.
- Increase in Chronic Diseases: The prevalence of chronic diseases, such as diabetes, cardiovascular conditions, and cancer, contributes to the demand for medications delivered in capsule form. Hard gelatin capsules are often used for sustained and controlled-release formulations.
- Growing Aging Population: The increasing number of elderly individuals requires various medications and supplements, boosting the demand for hard gelatin capsules as a preferred dosage form.
The hard gelatin capsules market faces several challenges, including:
- Health and Safety Concerns: There are growing concerns over the use of animal-derived gelatin in capsules. Some consumers and health professionals prefer vegetarian or vegan alternatives due to religious, ethical, or health reasons.
- Regulatory Issues: Different countries have varying regulations regarding the production and use of gelatin capsules. Compliance with these regulations can be complex and costly for manufacturers.
- Raw Material Sourcing: The production of gelatin involves sourcing animal bones and hides, which can be subject to fluctuations in availability and price. Additionally, the quality of raw materials can impact the final product.
- Environmental Impact: The environmental footprint of gelatin production, including issues related to waste management and resource consumption, is a growing concern. There is increasing pressure for more sustainable practices.
- Market Competition: The market is highly competitive, with numerous players offering similar products. This intense competition can lead to price wars and reduced profit margins.
Key Players of Hard Gelatin Capsules Industry:
- ACG Worldwide
- Lonza
- Qualicaps, Inc. (Mitsubishi Chemical Holdings Corporation)
- Sunil Healthcare Ltd.
- CapsCanada Corporation / Farmacapsulas
- Suheung Co., Ltd. (EmboCaps)
- Medi-Caps Ltd.
- NLL (Nector Lifesciences Ltd.)
- Natural Capsules
- Erawat Pharma
- Dah Feng Capsule (Biocaps)
- Lefan Capsule
- Qingdao Yiqing Medicinal Capsules Co., Ltd.
- Shanxi Guangsheng Medicinal Capsule
- Health Caps India
- Comed Chemicals
- Fortcaps Healthcare
- Shaoxing Zhongya Capsule
- Shree Pharma Caps
- Shaoxing Kangke Capsule
Regional Analysis: Hard Gelatin Capsules Market
The global hard gelatin capsules market is experiencing notable growth across various regions, driven by increasing demand for pharmaceutical and dietary supplement products. Here’s a brief regional analysis:
- North America: Dominates the market due to advanced healthcare infrastructure, high healthcare expenditure, and a strong pharmaceutical industry. The U.S. is a major contributor, with robust R&D activities and a significant demand for dietary supplements.
- Europe: Holds a substantial share, fueled by a well-established pharmaceutical sector and rising health awareness. The market is driven by innovations in capsule technology and increasing consumer preference for nutraceuticals.
- Asia-Pacific: Expected to witness the highest growth rate due to rapid industrialization, increasing healthcare investments, and a growing population. Emerging economies like China and India are key players, with expanding pharmaceutical manufacturing capacities and rising disposable incomes.
- Latin America: Shows moderate growth with potential due to improving healthcare infrastructure and increasing healthcare spending. Countries like Brazil and Mexico are significant contributors.
- Middle East & Africa: The market is growing gradually, supported by increasing investments in healthcare and pharmaceutical sectors. However, growth is slower compared to other regions due to economic and infrastructural challenges.
Browse full Report: https://www.futuremarketinsights.com/reports/hard-gelatin-capsules-market
Key Segments of Hard Gelatin Capsules Industry:
By Source:
In terms of source, the industry is divided into type-A (pork skin), type-B gelatine (animal bones & calf skin), and fish bone gelatine
By Size:
In terms of size, the industry is segregated into size “00” capsules, size “0” capsules, size “1” capsules, size “2” capsules, size “3” capsules, size “4” capsules, and size “5” capsules
By Route of Administration:
In terms of route of administration, the industry is divided into oral administration and inhalation.
By End User:
In terms of end user, the industry is segregated into pharmaceutical companies, cosmetic & nutraceutical companies, and CROs & CDMOs
By Region:
Key countries of North America, Latin America, Europe, East Asia, South Asia & Pacific, Middle East and Africa (MEA) have been covered in the report.
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain:
The global flavored empty capsule market size is estimated to increase from USD 349.1 million in 2024 to USD 667.7 million by 2034. The market was valued at USD 328.9 million at the end of 2023 and is forecast to exhibit Y-o-Y growth of 6.1 % in 2024.
The global empty capsule market share is projected to be worth USD 2,956.6 million in 2024. The sales of empty capsules are expected to expand at an 8% CAGR from 2024 to 2034, reaching USD 6,378.6 million by 2034.
The global advanced empty capsules market demand is anticipated to generate revenues of USD 905.6 million in 2023. Demand for advanced empty capsules is projected to develop at a CAGR of 7.4% and reach USD 1,856.1 million by 2033.
The global non-sterile outsourcing market growth is estimated to be worth USD 7,896.8 million in 2024 and anticipated to reach a value of USD 13,746.9 million by 2034. Sales are projected to rise at a CAGR of 5.7% over the forecast period between 2024 and 2034.
The global sales of medical chairs is estimated to be worth USD 8,524.8 million in 2024 and are anticipated to reach a value of USD 13,623.8 million by 2034. Sales are projected to rise at a CAGR of 4.8% over the forecast period between 2024 and 2034.
The global dialysis equipment market trends are estimated to be worth USD 11,126.0 million in 2024 and anticipated to reach a value of USD 17,780.9 million by 2034. Sales are projected to rise at a CAGR of 4.8% over the forecast period between 2024 and 2034.
The global caprolactam market forecast is estimated to be worth USD 16,447.9 million in 2024 and anticipated to reach a value of USD 24,113.8 million by 2034. Sales are projected to rise at a CAGR of 3.9% over the forecast period between 2024 and 2034.
The global pet cancer therapeutics market analysis are estimated to be worth USD 400.9 million in 2024 and are anticipated to reach a value of USD 898.6 million by 2034. Sales are projected to rise at a CAGR of 8.4% over the forecast period between 2024 and 2034.
The global infusion pump market opportunity is estimated to be worth USD 4,932.2 million in 2024 and anticipated to reach a value of USD 8,345.4 million by 2034. Sales are projected to rise at a CAGR of 5.4% over the forecast period between 2024 and 2034.
The global platelet rich plasma market development is estimated to be worth USD 444.4 million in 2024 and anticipated to reach a value of USD 1,163.1 million by 2034.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: [email protected]
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
